Harvey Jones looks over two FTSE 100 income stocks that have had a bumpy time of it lately, but are now starting to show ...

Chief executive Emma Walmsley is to leave GSK, it was announced on Monday, after nearly a decade in the role. She will be ...

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief ...

Pharmaceuticals firm GSK has announced a shock change at the very top, with CEO Dame Emma Walmsley opting to step down after ...

News 12 spoke with a health professional who emphasized that she is not taking sides in the political conversation, but is ...

Kenvue shares declined on Tylenol autism reports, creating a long-term buying opportunity for savvy investors. Click here to ...

GSK’s share price has regained some ground recently from the drags of legal and tariff concerns, but I think it's still ...

Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke ...

Stock futures are moving higher in premarket trading as investors monitor budget talks ahead of a potential government shutdown and look ahead to key labor market data later this week. Futures tied to ...

Shares of U.K. pharmaceutical giant GSK rallied on Monday after it turned to an insider to become its next CEO.

This review of the nitrosamines contamination problem in pharmaceuticals takes a look at how the crisis started and developed.

According to the Wall Street Journal, an upcoming HHS report was expected to suggest a potential link between Tylenol, when taken by pregnant women, and autism. In 2023, U.S. District Judge Denise ...